GeneDx Corp (WGS) - Bozor qiymatining balans qiymatiga nisbati

GeneDx Holdings Corp. (WGS) kompaniyasining korporativ logotipi

GeneDx Holdings Corp. (WGS) pediatrik genomik sekvenslashga e'tibor qaratgan holda operatsion daromadlilikka erishmoqda, xizmatlariga bo'lgan talab esa iqtisodiyotdan mustaqil qolmoqda va 7.89 darajasida turibdi. Kompaniya o'zining noyob ekzom arxiviga ega bo'lganligi sababli narxlarni belgilash imkoniyatini saqlab qolmoqda. GeneDx Holdings Corp. (WGS) uchun ushbu kunlik narxlar grafigi genetik testlar ishlab chiquvchisining kotirovkalarini aks ettiradi. Biroq, tarmoq laboratoriyalari tomonidan aktivlarni arzon sotish xavfi va shifoxona shartnomalari uchun qattiq raqobat jiddiy tahdidlar tug'dirmoqda.

GeneDx Corp (WGS) - Bozor kapitallashuvining balans qiymatiga nisbati 28.04.2023dan 29.10.2026gacha

GeneDx Holdings Corp. kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi GeneDx Holdings Corp.|WGS - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Sema4|WGS - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati GeneDx|WGS - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati genedx.com|WGS - Kompaniyaning balans aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati GeneDx Holdings Corp.|WGS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Sema4|WGS - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar Sema4|WGS - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzlari GeneDx|Tezkor likvidlik ko‘rsatkichi genedx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
WGS - Kompaniya foydasi
Kompaniyaning jamlanma tahlili:GeneDx Holdings Corp. - WGS
Sema4 yetakchi tovari

Ushbu koeffitsient kapitalning haddan tashqari qimmat yoki arzon baholanganligini aniqlash uchun biznesning bozor qiymatini uning sof aktivlari bilan solishtirish orqali GeneDx Holdings Corp. (WGS) investitsiya ishonchliligini belgilaydi. GURU.Markets platformasidagi joriy bozor qiymatining buxgalteriya qiymatiga nisbatini tahlil qilish orqali investor butun genom sekvensirlashining kengayishi va noyob kasalliklar diagnostikasidagi noyob genetik ma'lumotlarni monetizatsiya qilishga oid bozor kutganlarini aniqlashi mumkin.

Raqobatdosh kompaniyalar tahlili

TEM: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati QGEN|Bozor qiymatining balans qiymatiga nisbati Ionis|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor kapitallashuvining balans qiymatiga nisbati RNA|Bozor kapitallashuvining balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati RARE (Ultragenyx Pharmaceutical)|Bozor qiymatining xususiy kapitalga nisbati beamtx.com|Sarepta - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Twist Bioscience Inc|10x Genomics Corp (TXG) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati NTLA|STOK (Stoke Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti biolifesolutions.com BLFS|Bozor kapitallashuvining balans qiymatiga nisbati WVE|Maze Therapeutics, Inc. - Kapitallashuvning balans qiymatiga nisbati|Sionna Pharma - Kapitallashuvning sof aktivlarga nisbati|PRME: Kapitallashuvning balans qiymatiga nisbati|TSHA: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati QURE (uniqure.com)|MGTX: Bozor kapitallashuvining balans qiymatiga nisbati|REGENXBIO Inc - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Solid Bio|Bozor qiymatining balans qiymatiga koeffitsiyenti Ocugen Pharma OCGN|Bozor qiymatining balans qiymatiga nisbati Pacific Biosciences (PACB)|Bozor qiymatining balans qiymatiga nisbati BNTC (benitec.com)|Bozor kapitallashuvining balans qiymatiga nisbati DSGN (Design Therapeutics, Inc.)|RCKT: Kapitallashuvning balans qiymatiga nisbati|4D Molecular Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Lexeo Therapeutics LXEO|korrobio.com (KRRO) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati EDIT|SLN (Silence Therapeutics plc) - Bozor kapitallashuvining balans qiymatiga nisbati|PRQR - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Codexis, Inc. (CDXS)|Balans qiymatiga nisbatan bozor kapitallashuvi Sangamo BioSciences|Nautilus Bio - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati MGX|Precision BioSciences - Bozor kapitallashuvining balans qiymatiga nisbati|Generation Bio Co. (GBIO) - Kapitallashuvning sof aktivlarga nisbati|Boundless Bio, Inc (BOLD) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Exicure (XCUR)|Bozor qiymatining balans qiymatiga nisbati Imunon Inc|PHIO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Mustang Bio, Inc. (MBIO)|RNAZ: Sof aktivlarga nisbatan bozor kapitallashuvi|Bionano Genomics - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Applied DNA Corp (APDN)|BLUE: Kapitallashuvning sof aktivlarga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|OMGA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Singular Genomics Systems, Inc. OMIC|Bozor qiymatining balans qiymatiga nisbati Regulus Therapeutics Inc|Syros Pharmaceuticals, Inc (SYRS) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati TBIO|traconpharma.com - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Unity Biotechnology, Inc. UBX